1. Schneider, J. S. (1998) GM1 ganglioside and neurotrophic factors in the treatment of Parkinson’s disease. Neuroscience News
1, 10–16.
2. Fahn, S. and Cohen, G. (1992) The oxidant stress hypothesis in Parkinson’s disease: evidence supporting it. Ann. Neurol.
32, 804–812.
3. Mochizuki, H., Goto, K., Mori, H., and Mizuno, Y. (1996) Histochemical detection of apoptosis in Parkinson’s disease. J. Neurol. Sci.
137, 120–123.
4. Tompkins, M. M., Basgall, E. J., Zamrini, E., and Hill, W. D. (1997) Apoptotic-like changes in Lewy-body associated disorders and normal aging in substantia nigra neurons. Am. J. Pathol.
150, 119–131.
5. Ruberg, M., Brugg, B., Prigent, A., Hirsch, E., Brice, A., and Agid, Y. (1997) Is differential regulation of mitochondrial transcripts in Parkinson’s disease related to apoptosis? J. Neurochem.
68, 2098–2110.